Toxicology of smokeless tobacco: Implications for immune, reproductive, and cardiovascular systems

Journal of Toxicology and Environmental Health - Part B: Critical Reviews

Volumn 15, Issue 5, 2012, Pages 317-331

  Willis, Daniel ^a   Popovech, Mary ^a   Gany, Francesca ^b   Zelikoff, Judith ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETEL EXTRACT; C REACTIVE PROTEIN; CD11B ANTIGEN; CD3 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 8; NICOTINE;

ADVERSE OUTCOME; ALVEOLAR BONE LOSS; ARTERIAL WALL THICKNESS; CARDIOVASCULAR DISEASE; CYTOKINE PRODUCTION; DENTAL CARIES; DIASTOLIC BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; GINGIVITIS; HEART INFARCTION; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART RATE; HUMAN; HYPERTENSION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOTOXICITY; KERATOSIS; LEUKOPLAKIA; MOUTH CANCER; NONHUMAN; OUTCOME ASSESSMENT; PERINATAL MORTALITY; PERIODONTITIS; PREECLAMPSIA; PREMATURE LABOR; PREVALENCE; REPRODUCTIVE TOXICITY; REVIEW; SEMEN ANALYSIS; SERTOLI CELL; SMOKELESS TOBACCO; SPERMATID; SPERMATOGENESIS; SPERMATOZOON MOTILITY; STILLBIRTH; STROKE; SYSTOLIC BLOOD PRESSURE;

ANIMALS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; HUMANS; IMMUNE SYSTEM; IMMUNE SYSTEM DISEASES; OUTCOME ASSESSMENT (HEALTH CARE); REPRODUCTION; TOBACCO, SMOKELESS;

EID: 84864886917     PISSN: 10937404     EISSN: 15216950     Source Type: Journal    
DOI: 10.1080/10937404.2012.689553     Document Type: Review

References (91)

1. Accortt, N. A., Waterbor, J. W., Beall, C., and Howard, G. 2002. Chronic disease mortality in a cohort of smokeless tobacco users. Am. J. Epidemiol. 156: 730-37. (Pubitemid 35155179)
2. Archana, K., Gautam, A. K., Lakkad, B. C., and Kumar, S. 2011. In utero and lactation exposure of mice to pan masala: effect on dams and pregnancy outcome. J. Environ. Pathol. Toxicol. Oncol. 30: 71-81.
3. Aro, P., Ronkainen, J., Storskrubb, T., Vieth, M., Engstrand, L., Johansson, S. E., Bolling-Sternevald, E., Bolinder, G., Alving, K., Talley, N. J., and Agréus, L. 2010. Use of tobacco products and gastrointestinal morbidity: An endoscopic population-based study (the Kalixanda study). Eur. J. Epidemiol. 25: 741-50.
4. Asplund, K., Nasic, S., Janlert, U., and Stegmayr, B. 2003. Smokeless tobacco as a possible risk factor for stroke in men: A nested case-control study. Stroke 34: 1754-59. (Pubitemid 36842641)
5. Aydos, K., Güven, M. C., Can, B., and Ergün, A. 2001. Nicotine toxicity to the ultrastructure of the testis in rats. Br. J. Urol. Int. 88: 622-26. (Pubitemid 34293808)
6. Bagchi, D., Hassoun, E. A., Bagchi, M., and Stohs, S. J. 1995. Protective effects of free radical scavengers and antioxidants against smokeless tobacco extract (STE)-induced oxidative stress in macrophageJ774A.1 cell cultures. Arch. Environ. Contam. Toxicol. 29: 424-28.
7. Bagchi, M., Balmoori, J., Bagchi, D., Ray, S. D., Kuszynski, C., and Stohs, S. J. 1999. Smokeless tobacco, oxidative stress, apoptosis, and antioxidants in human oral keratinocytes. Free Rad. Biol. Med. 26: 992-1000. (Pubitemid 29198372)
8. Bates, C., Fagerström, K., Jarvis, M. J., Kunze, M., McNeill, A., and Ramström, L. 2003. European Union policy on smokeless tobacco: A statement in favour of evidence based regulation for public health. Tobacco Control. 12: 360-67. (Pubitemid 39452036)
9. Benowitz, N. L. 2011. Smokeless tobacco as a nicotine delivery device: Harm or harm reduction? Clin. Pharmacol. Ther. 90:491-93.
10. Bickel, M. 1993. The role of interleukin-8 in inflammation and mechanisms of regulation. J. Periodontol. 64:456-60.
11. Boffetta P., Aagnes B., Weiderpass E., and Andersen A. 2005. Smokeless tobacco use and risk of cancer of the pancreas and other organs. Int. J. Cancer 114:992-95.
12. Boffetta, P., Hecht, S., Gray, N., Gupta, P., and Straif, K. 2008. Smokeless tobacco andcancer. Lancet Oncol. 9: 667-75.
13. Bolinder, G. M., Ahlborg, B. O., and Lindell, J. H. 1992. Use of smokeless tobacco: Blood pressure elevation and other health hazards found in a large-scale population survey. J. Intern. Med. 232: 327-34.
14. Brunnemann, K. D., and Hoffmann, D. 1992. Chemical composition of smokeless tobacco products. In Smokeless tobacco or health. An international perspective (Smoking and Tobacco Control Monograph No. 2; NIH Publ. No. 93-3461), 96-108. Bethesda, MD: National Cancer Institute.
15. Centers for Disease Control and Prevention. 2010. State-specific prevalence of cigarette smoking and smokeless tobacco use among adults-United States, 2009. Morbid. Mortal. Weekly Rep. 59: 1400-6.
16. Changrani, J., and Gany, F. 2005. Paan and Gutka in the United States: An emerging threat. J. Immigrat. Health 7: 103-8. (Pubitemid 40468380)
17. Chao, A., Thun,M. J., Henley, S. J., Jacobs, E. J., McCullough, M. L., and Calle, E. E. 2002. Cigarette smoking, use of other tobacco products and stomach cancer mortality in US adults: The Cancer Prevention Study II. Int. J. Cancer 101: 380-389. (Pubitemid 34987526)
18. Chen, C. L., Chi, C. W., and Liu, T. Y. 2002. Hydroxyl radical formation and oxidative DNA damage induced by areca quid in vivo. J. Toxicol. Environ. Health A 65: 327-36.
19. Christen, A. G., Swanson, B. Z., Glover, E. D., and Henderson, A. H. 1982. Smokeless tobacco: The folklore and social history of snuffing, sneezing, dipping, and chewing. J.Am. Dent. Assoc. 105: 821-29.
20. Colilla, S. A. 2010. An epidemiologic review of smokeless tobacco health effects and harm reduction potential. Regul. Toxicol. Pharmacol. 56: 197-211.
21. Conde-Agudelo, A., Althabe, F., Belizan, J. M., and Kafury-Goeta, A. C. 1999. Cigarette smoking during pregnancy and risk of preeclampsia: A systematic review. Am. J. Obstet. Gynecol. 181: 1026-35. (Pubitemid 29503633)
22. Connolly, G. N., and Alpert, H. R. 2008. Trends in the use of cigarettes and other tobacco products, 2000-2007. J. Am. Med. Assoc. 299: 2629-30. (Pubitemid 351831608)
23. Djordjevic, M. V., and Doran, K. A. 2009. Nicotine content and delivery across tobacco products. Handbook Exp. Pharmacol. 192: 61-82.
24. Eliasson, M., Lundblad, D., and Hägg, E.. 1991. Cardiovascular risk factors in young snuffusers and cigarette smokers. J. Intern. Med. 230: 17-22.
25. England, L. J., Levine, R. J., Mills, J. L., Klebanoff, M. A., Yu, K. F., and Cnattingius S. 2003. Adverse pregnancy outcomes in snuff users. Am. J. Obstet. Gynecol. 189: 939-43. (Pubitemid 37373873)
26. Foulds, J., and Kozlowski, L. 2007. Snus-what should the public response be? Lancet 369: 1976-78.
27. Grady, D., Greene, J., Daniels, T. E., Ernster, V. L., Robertson, P. B., Hauck, W., Greenspan, D., Greenspan, J., and Silverman, S. Jr. 1990. Oral mucosal lesions found in smokeless tobacco users. J. Am. Dent. Assoc. 121: 117-23.
28. Granberry,M. C., Smith, E. S., III, Troillet, R. D., and Eidt, J. F. 2003. Forearm endothelial response in smokeless tobacco users compared with cigarette smokers and nonusers of tobacco. Pharmacother.23: 974-78. (Pubitemid 36903997)
29. Gupta, P. C. 1996. Socio-demographic characteristic of tobacco use among 99,598 individuals in Bombay, India using hand-held computers. Tob. Control 5: 114-20. (Pubitemid 126670518)
30. Gupta, P. 2001. Regional Summary for Southeast Asia World Health Organization. 2001.
31. Gupta, P. C., and Subramoney, S. 2004. Smokeless tobacco use, birth weight, and gestational age: Population based, prospective cohort study of 1217 women in Mumbai, India. Br. Med. J. 328: 1538.
32. Gupta, P. C., Pednekar, M. S., Parkin, D. M., and Sankaranarayanan, R. 2005. A cohort study of 99,570 individuals in Mumbai, India for tobacco-associated mortality. Int. J. Epidemiol. 34: 1395-402. (Pubitemid 41819551)
33. Gupta, P. C., and Subramoney, S. 2006. Smokeless tobacco use and risk of stillbirth: A cohort study in Mumbai, India. Epidemiol. 17: 47-51.
34. Gupta, B. K., Kaushik, A., Panwar, R. B., Chaddha, V. S., Nayak, K. C., Singh, V. B., Gupta, R., and Raja, S. 2007. Cardiovascular risk factors in tobacco-chewers: A controlled study. J. Assoc. Physicians India 55: 27-31.
35. Guzik, K., and Potempa, J. 2008. Friendly fire against neutrophils: Proteolytic enzymes confuse the recognition of apoptotic cells by macrophages. Biochimie 90: 405-415. (Pubitemid 351172574)
36. Haglund, B., Eliasson, M., Stenbeck, M., and Rosén, M. 2007. Is moist snuff use associated with excess risk of IHD or stroke? A longitudinal follow-up of snuff users in Sweden. Scand. J. Public Health 35: 618-22. (Pubitemid 350176909)
37. Henley, S. J., Thun, M. J., Connell, C., and Calle, E. E. 2005. Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). Cancer Causes Control 16: 347-58. (Pubitemid 40897827)
38. Hergens M. P., Alfredsson, L., Bolinder, G., Lambe, M., and Ye, W. 2007. Long-term use of Swedish moist snuff and the risk of myocardial infarction amongst men. J. Intern. Med. 262: 351-59. (Pubitemid 47246970)
39. Hirsch, J. M., Heyden, G., and Thailander, H. 1982. A clinical histomorphological and histochemical study of snuff-induced lesions of varying severity. J. Oral Pathol. 11: 387-98. (Pubitemid 12035511)
40. Hoffmann, D., and Hoffmann, I. 1997. The changing cigarette, 1950-1995. J. Toxicol. Environ. Health 50: 307-64.
41. Hoffmann, D., Hoffmann, I., and El-Bayoumy, K. 2001. The less harmful cigarette: A controversial issue. A tribute to Ernst L. Wynder. Chem. Res. Toxicol. 14: 767-90. (Pubitemid 32663874)
42. International Agency for Research on Cancer. 2007. Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC Monogr. Eval. Carcinogen. Risks Hum. 89. Genevas: WHO.
43. International Union Against Cancer. 1996. Tobacco control fact sheet 8. Geneva: International Union Against Cancer, Tobacco and Cancer Programme.
44. Javed, F., Chotai, M.,Mehmood, A., and Almas, K. 2010. Oral mucosal disorders associated with habitual gutka usage: A review. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 109: 857-64.
45. Johnson, G. K., Poore, T. K., Squier, C. A., Wertz, P. W., Reinhardt, R. A., and Vincent, R. A. 1994. Prostaglandin E2 and interleukin-1 levels in smokeless tobaccoinduced oral mucosal lesions. J. Periodont. Res. 29: 430-38.
46. Johnson, G. K., and Slach, N. A. 2001. Impact of tobacco use on periodontal status. J. Dent. Educ. 65: 313-21.
47. Johnson, G. K., Guthmiller, J. M., Joly, S., Organ, C. C., and Dawson, D. V. 2010. Interleukin-1 and interleukin-8 in nicotine-and lipopolysaccharide- exposed gingival keratinocyte cultures. J. Periodontal Res. 45: 583-88.
48. Kallischnigg G., Weitkunat, R., and Lee, P. N. 2008. Systematic review of the relation between smokeless tobacco and nonneoplastic oral diseases in Europe and the United States. BMC Oral Health 8. doi:10.1186/1472-6831-8-1
49. Kozlowski, L. T. 2002. Harm reduction, public health, and human rights: Smokers have a right to be informed of significant harm reduction options. Nicotine Tobacco Res. 4(suppl. 2): S55-60. (Pubitemid 36104362)
50. Laytragoon-Lewin, N., Bahram, F., Rutqvist, L. E., Turesson, I., and Lewin, F. 2011. Direct effects of pure nicotine, cigarette smoke extract, Swedish-type smokeless tobacco (Snus) extract and ethanol on human normal endothelial cells and fibroblasts. Anticancer Res. 31: 1527-34.
51. Lee, P. N., and Hamling, J. 2009. Systematic review of the relation between smokeless tobacco and cancer in Europe and North America. BMC Med. 7: 36.
52. Lee, P. N. 2011. Summary of the epidemiological evidence relating snus to health. Reg. Toxicol. Pharmacol. 59: 197-214.
53. Lombard, C., Farthing, D., Sun, J., Fariss, M. W., and McKallip, R. J. 2010. Reference moist smokeless tobacco-induced apoptosis in human monocytes/macrophages cell line MM6. Int. Immunopharmacol. 10: 1029-40.
54. Luebke, R. W., Parks, C., and Luster, M. I. 2004. Suppression of immune function and susceptibility to infections in humans: Association of immune function with clinical disease. J. Immunotoxicol. 1: 15-24.
55. Luster, M. I., Ackermann, M. F., Germolec, D. R., and Rosenthal, G. J. 1989. Perturbations of the immune system by xenobiotics. Environ. Health Perspect. 81: 157-62. (Pubitemid 19156881)
56. Luster, M. I., and Rosenthal, G. J. 1993. Chemical agents and the immune response. Environ. Health Perspect. 100: 219-26. (Pubitemid 23197100)
57. McFarlane, C. G., and Meikle, M. C. 1991. Interleukin-2, interleukin-2 receptor and interleukin-4 levels are elevated in the sera of patients with periodontal disease. J. Periodont. Res. 26: 402-8.
58. Melikian, A. A., and Hoffmann, D. 2009. Smokeless tobacco: A gateway to smoking or a way away from smoking. Biomarkers 14: 85-89.
59. Nair, U. J., Ammigan, N., Kayal, J. J., and Bhide, S. V. 1991. Species differences in hepatic pulmonary and upper gastrointestinal tract biotransformation enzymes on long-term feeding of masheri-A pyrolyzed tobacco product. Digest. Dis. Sci. 36: 293-98.
60. National Cancer Institute. 1992. Smokeless tobacco or health: An international perspective. Washington, DC: U.S. Department of Health and Human Services, National Institutes of Health.
61. Norberg M., Lundqvist G., Nilsson M., Gilljam H., and Weinehall L. 2011. Changing patterns of tobacco use in a middle-aged population: the role of snus, gender, age,and education. Glob. Health Action 4. doi: 10.3402/gha.v4i0.5613
62. Offenbacher, S., and Weathers, D. R. 1985. Effects of smokeless tobacco on the periodontal, mucosal and caries status of adolescent males. J. Oral Pathol. 14: 169-81.
63. Page, R. M., and Danielson, M. 2011. Multicountry, cross-national comparison of youth tobacco use: findings from global schoolbased health surveys. Addict. Behav. 36: 470-78.
64. Pandey, A., Patni, N., Sarangi, S., Singh, M., Sharma, K., Vellimana, A. K., and Patra,S. 2009. Association of exclusive smokeless tobacco consumption with hypertension in an adult male rural population of India. Tobabbo Induced Dis. 5: 15.
65. Payne, J. B., Johnson, G. K., Reinhardt, R. A., and Schmid, M. 1998. Histological alterations following short-term smokeless tobacco exposure in humans. J. Periodont. Res. 33: 274-79. (Pubitemid 128528724)
66. Petro, T. M., and Zhang, S. 1997. The effect of smokeless tobacco extract on murine T cell cytokine production. Immunopharmacol. 36: 17-26. (Pubitemid 27153474)
67. Phukan, R. K., Ali, M. S., Chetia, C. K., and Mahanta, J. 2002. Betel nut and tobacco chewing: Potential risk factors of cancer of oesophagus in Assam, India. Br. J. Cancer 85: 661-67. (Pubitemid 32929461)
68. Roberts, D. L. 1988. Natural tobacco flavor. Recent Adv. Tobacco Sci. 14: 49-81.
69. Rodu, B., and Jansson C. 2004. Smokeless tobacco and oral cancer: A review of the risks and determinants. Crit. Rev. Oral Biol. Med. 15: 252-63. (Pubitemid 44566046)
70. Rogers, J. M. 2009. Tobacco and pregnancy. Reprod. Toxicol. 28: 152-60.
71. Said, T. M., Ranga, G., and Agarwal, A. 2005. Relationship between semen quality and tobacco chewing in men undergoing infertility evaluation. Fertil. Steril. 84: 649-53. (Pubitemid 41317723)
72. Shankaran, K., Kandarkar, S. V., Contractor, Q. Q., Kalro, R. H., and Desai, H. G. 1994. Electron microscopic observations in gastric mucosa of habitual tobacco chewers. Indian J. Med. Res. 99: 267-71. (Pubitemid 24215224)
73. Shulman, J. D., Beach, M. M., and Rivera-Hidalgo, F. 2004. The prevalence of oral mucosal lesions in U.S. adults: Data from the Third National Health and Nutrition Examination Survey, 1988-1994. J. Am. Dent. Assoc. 135: 1279-86. (Pubitemid 39329655)
74. Siegel, D., Benowitz, N., Ernster, V. L., Grady, D. G., and Hauck, W. W. 1992. Smokelesstobacco, cardiovascular risk factors, and nicotine and cotinine levels in professional baseball players. Am. J. Public Health 82: 417-21.
75. Sinha, D. N., Gupta, P. C., Pednekar, M. S., Jones, J. T., and Warren, C. W. 2002. Tobacco use among school personnel in Bihar, India. Tobacco Control 11: 82-83.
76. Sinha, D. N., Palipudi, K. M., Rolle, I., Asma, S., and Rinchen, S. 2011. Tobacco use among youth and adults in member countries of South-East Asia region: Review of findings from surveys under the global tobacco surveillance system. Indian J. Public Health 55: 169-76.
77. Soehnlein, O., and Lindbom L. 2010. Phagocyte partnership during the onset and resolution of inflammation. Nat. Rev. Immunol. 10: 427-39.
78. Squires, W. G., Brandon, T. A., Zinkgraf, S., Bonds, D., Hartung, G. H., Murray, T., Jackson, A. S. and Miller, R. R. 1984. Hemodynamic effects of oral smokeless tobacco in dogs and young adults. Prev. Med. 13: 195-206. (Pubitemid 14108014)
79. Stanfill, S. B., Connolly, G. N., Zhang, L., Jia, L. T., Henningfield, J. E., Richter, P., Lawler, T. S., Ayo-Yusuf, O. A., Ashley, D. L., and Watson, C. H. 2011. Global surveillance of oral tobacco products: total nicotine, unionised nicotine and tobaccospecific N-nitrosamines. Tobacco Control 20:e2. doi:10.1136/tc.2010.03746
80. Stepanov, I., Hecht, S. S., Ramakrishnan, S., and Gupta, P. C. 2005. Tobacco-specific nitrosamines in smokeless tobacco products marketed in India. Int. J. Cancer. 116: 16-19. (Pubitemid 40827750)
81. Suzuki, H., Gao, X. P., Olopade, C. O., Jaffe, H. A., Pakhlevaniants, S., and Rubinstein, I. 1996. Aqueous smokeless tobacco extracts impairs endothelium-dependent vasodilation in the oral mucosa. J. Appl. Physiol. 81: 225-31. (Pubitemid 26255513)
82. Trivedy C. R., Craig G., and Warnakulasuriya S. 2002. The oral health consequences of chewing areca nut. Addict. Biol. 7: 115-25. (Pubitemid 34087915)
83. Tomar, S. L., and Henningfield, J. E. 1997. Review of the evidence that pH is a determinant of nicotine dosage from oral use of smokeless tobacco. Tob. Control. 6: 219-25. (Pubitemid 127685528)
84. Wallenfeldt, K., Hulthe, J., Bokemark, L., Wikstrand, J., and Fagerberg, B. 2001. Carotid and femoral atherosclerosis, cardiovascular risk factors and C-reactive protein in relation to smokeless tobacco use or smoking in 58-year-old men. J. Intern. Med. 250: 492-501. (Pubitemid 34008759)
85. Wikström, A. K., Cnattingius, S., and Stephansson, O. 2010a. Maternal use of Swedish snuff (snus) and risk of stillbirth. Epidemiol. 21: 772-78.
86. Wikström, A. K., Stephansson, O., and Cnattingius S. 2010b. Tobacco use during pregnancy and preeclampsia risk: Effects of cigarette smoking and snuff. Hypertension 55: 1254-59.
87. Wikström, A. K, Cnattingius, S., Galanti, M. R., Kieler, H., and Stephansson, O. 2010c. Effect of Swedish snuff (snus) on preterm birth. Br. J. Obstet. Gynecol. 117: 1005-10.
88. Winn, D. M. 1997. Epidemiology of cancer and other systemic effects associated with the use of smokeless tobacco. Adv. Dent. Res. 11: 313-21.
89. Winn D. M. 2001. Tobacco use and oral disease. J. Dent. Educ. 65: 306-12.
90. World Health Organization. 1997. Tobacco or health: A global status report. Geneva:World Health Organization.
91. Yang, M. J., Chung, T. C., Yang, M. J., Hsu, T. Y., and Ko, Y. C. 2001. Betal quid and chewing and risk of adverse birth outcomes among aborigines in eastern Taiwain. J. Toxicol. Environ. Health A 64: 465-72.